Sangrix Inc. (SGRX): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2024-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report this line under the concept TickerFacts maps.

$3.83M
Year ended 2024-06-30
-63.3%
3-year compound annual growth
-46.9%
5-year compound annual growth
$91.45M2017-06-30: $58.21M2018-06-30: $91.45M2019-06-30: $90.43M2020-06-30: $22.22M2021-06-30: $77.50M2022-06-30: $10.83M2023-06-30: $10.83M2024-06-30: $3.83M$3.83M
2017-06-30 Cost of Revenue (USD) 2024-06-30
Period endedCost of RevenueChange YoYSource filing
2024-06-30$3.83M-64.6%2026-09-18, From 2023-07-01
2023-06-30$10.83M0.0%2024-12-26, From 2022-07-01
2022-06-30$10.83M-86.0%2025-10-31, From 2021-07-01
2021-06-30$77.50M+248.8%2021-11-15, From 2020-07-01
2020-06-30$22.22M-75.4%2021-11-15, From 2019-07-01
2019-06-30$90.43M-1.1%2020-11-17, From 2018-07-01
2018-06-30$91.45M+57.1%2020-11-17, From 2017-07-01
2017-06-30$58.21Mn/a2019-11-06, From 2016-07-01